Hutchmed China Ltd ADR (HCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 38,170 | 101,094 | -360,386 | -167,041 | -115,517 |
| Depreciation Amortization | 12,341 | 8,207 | 8,664 | 7,190 | 6,061 |
| Accounts receivable | -38,545 | -21,336 | -14,451 | -35,634 | -4,693 |
| Accounts payable and accrued liabilities | 6,194 | -32,542 | 29,938 | 9,565 | 7,651 |
| Other Working Capital | -62,169 | 71,146 | 58,704 | 32,458 | 29,273 |
| Other Operating Activity | 44,506 | 92,689 | 8,932 | -50,761 | 15,159 |
| Operating Cash Flow | $497 | $219,258 | $-268,599 | $-204,223 | $-62,066 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -79,405 | -285,029 | 316,440 | -434,612 | -103,535 |
| PPE Investments | -17,933 | -32,612 | -36,664 | -16,756 | -19,580 |
| Net Acquisitions | N/A | -2,990 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | 324 | N/A | N/A |
| Other Investing Activity | 1,278 | 29,495 | 16,488 | 145,048 | -2,326 |
| Investing Cash Flow | $-96,060 | $-291,136 | $296,588 | $-306,320 | $-125,441 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 36,199 | 61,705 | 17,753 | N/A | N/A |
| Debt Repayment | -30,592 | N/A | -26,923 | N/A | N/A |
| Common Stock Issued | 790 | 5,094 | 174 | 717,319 | 318,934 |
| Common Stock Repurchased | -36,064 | -9,071 | -48,084 | -27,309 | -12,904 |
| Dividend Paid | -1,000 | -9,068 | -25,600 | -9,894 | -1,462 |
| Other Financing Activity | 0 | 0 | -83 | -30,088 | -8,134 |
| Financing Cash Flow | $-30,667 | $48,660 | $-82,763 | $650,028 | $296,434 |
| Exchange Rate Effect | -3,401 | -6,471 | -9,490 | 2,427 | 5,546 |
| Beginning Cash Position | 283,589 | 313,278 | 377,542 | 235,630 | 121,157 |
| End Cash Position | 153,958 | 283,589 | 313,278 | 377,542 | 235,630 |
| Net Cash Flow | $-129,631 | $-29,689 | $-64,264 | $141,912 | $114,473 |
| Free Cash Flow | |||||
| Operating Cash Flow | 497 | 219,258 | -268,599 | -204,223 | -62,066 |
| Capital Expenditure | -17,933 | -32,612 | -36,664 | -16,756 | -19,580 |
| Free Cash Flow | -17,436 | 186,646 | -305,263 | -220,979 | -81,646 |